Position in LLY
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$1,872,310
+$649,016 QoQ
Shares Held
1,561
+17.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.53%
of 13F equity value
Holder Rank
#2,554
of 4,605 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026United Advisor Group, LLC holds $12,073,291 across 8 Drug Manufacturers - General names. LLY ranks #3 (15.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
9,007 | $2,287,507 | |
| 2 | PFE |
Pfizer Inc
|
89,061 | $2,144,588 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
1,561 | $1,872,310 | |
| 4 | MRK |
Merck & Co., Inc.
|
14,125 | $1,815,062 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
28,224 | $1,626,266 | |
| 6 | ABBV |
AbbVie Inc.
|
5,691 | $1,432,083 | |
| 7 | AMGN |
Amgen Inc
|
1,429 | $517,469 | |
| 8 | NVO |
Novo Nordisk A S
|
7,885 | $378,006 |
All Filings in LLY
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,872,310 | 1,561 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $1,223,294 | 1,330 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $1,598,049 | 1,487 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $910,259 | 1,193 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $628,301 | 806 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $450,120 | 545 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $318,064 | 412 | Shares | Sole | 2025-02-24 | |
| 2024-09-30 | $531,564 | 600 | Shares | Sole | 2024-10-30 | |
| No filing history on record for this holder in this stock. | ||||||